Acro Biomedical Co., Ltd.
ACBM
$0.03
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -70.81% | 267.68% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -70.81% | 267.68% | |||
| Operating Income | 70.81% | -267.68% | |||
| Income Before Tax | 51.14% | -203.06% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 51.14% | -203.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 51.14% | -203.06% | |||
| EBIT | 70.81% | -267.68% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 42.86% | -200.00% | |||
| Normalized Basic EPS | 71.43% | -250.00% | |||
| EPS Diluted | 42.86% | -200.00% | |||
| Normalized Diluted EPS | 71.43% | -250.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||